Immune checkpoint

Results: 7



#Item
1CME  Assessing the Emerging Role of Checkpoint Inhibition and Other Immune Therapies in Lymphoma  Dates of certification: July 31, 2016, to July 31, 2017

CME Assessing the Emerging Role of Checkpoint Inhibition and Other Immune Therapies in Lymphoma Dates of certification: July 31, 2016, to July 31, 2017

Add to Reading List

Source URL: gotoper-com.s3.amazonaws.com

- Date: 2016-09-06 09:15:40
    2PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Jeffrey R. Infante1, Aung Naing2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish Patel1,8 ,

    PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Jeffrey R. Infante1, Aung Naing2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish Patel1,8 ,

    Add to Reading List

    Source URL: www.armobio.com

    Language: English - Date: 2015-12-11 00:15:30
    3PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2,

    PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2,

    Add to Reading List

    Source URL: www.armobio.com

    Language: English - Date: 2015-12-11 00:15:35
    4ASCO Annual Meeting - Chicago, IL, May 29 –June 2, 2015; Abstract #3017  Poster #: 343 A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors. Jeffrey R. Infante1,

    ASCO Annual Meeting - Chicago, IL, May 29 –June 2, 2015; Abstract #3017 Poster #: 343 A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors. Jeffrey R. Infante1,

    Add to Reading List

    Source URL: www.armobio.com

    Language: English - Date: 2015-12-11 00:15:33
    5Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology  Partnership aims to advance development of novel immune checkpoint

    Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology  Partnership aims to advance development of novel immune checkpoint

    Add to Reading List

    Source URL: sunstone.eu

    Language: English - Date: 2016-01-04 04:51:17
      6Award ID: DP150061 Project Title: Preclinical Development of a Therapeutic Enzyme for Immune Checkpoint Inhibition in Cancer Award Mechanism:

      Award ID: DP150061 Project Title: Preclinical Development of a Therapeutic Enzyme for Immune Checkpoint Inhibition in Cancer Award Mechanism:

      Add to Reading List

      Source URL: www.cprit.state.tx.us

      Language: English - Date: 2014-11-20 01:49:50
      7Strong grasp of immune response dynamics will enhance checkpoint blockade

      Strong grasp of immune response dynamics will enhance checkpoint blockade

      Add to Reading List

      Source URL: medicalxpress.com

      Language: English - Date: 2015-05-03 06:19:38